There is growing evidence for dysfunctional glutamatergic excitation and/or gammaaminobutyric acid (GABA)ergic inhibition in patients with multiple sclerosis (MS). Cognitive impairment may occur during the early stages of MS and hippocampal abnormalities have been suggested as biomarkers. However, researchers have not clearly determined whether changes in hippocampal GABA and glutamate (Glu) levels are associated with cognitive impairment and aberrant neural activity in patients with MS. We used magnetic resonance spectroscopy to measure GABA+ and Glu levels in the left hippocampal region of 29 patients with relapsingremitting MS and 29 healthy controls (HCs). Resting-state functional connectivity (FC) with the hippocampus was also examined. Compared to HCs, patients exhibited significantly lower GABA+ and Glu levels, which were associated with verbal and visuospatial memory deficits, respectively. Patients also showed decreased FC strengths between the hippocampus and several cortical regions, which are located within the default mode network. Moreover, hippocampal GABA+ levels and Glu/GABA+ ratios correlated with the FC strengths in HCs but not in patients with MS. This study describes a novel method for investigating the complex relationships among excitatory/inhibitory neurotransmitters, brain connectivity and cognition in health and disease.
the pathogenic effects of hippocampal abnormalities are implicated in MS-related cognitive impairment (Preziosa et al., 2016; Sacco et al., 2015; Sumowski et al., 2016; van Geest, Westerik, van der Werf, Geurts, & Hulst, 2016) . The hippocampus is a key region involved in memory (Eichenbaum, 2000) and is vulnerable in patients with relapsing-remitting MS (RRMS; Chiaravalloti & DeLuca, 2008; MacKenzie-Graham et al., 2016) . Decreased fractional anisotropy (Planche et al., 2016) , reduced functional activity (Hulst et al., 2015; Sweet, Rao, Primeau, Mayer, & Cohen, 2004) , microglial activation, and extensive demyelination (Geurts et al., 2007) in the hippocampus have been reported in previous imaging and postmortem studies.
Gamma-aminobutyric acid (GABA) and glutamate (Glu) are the main inhibitory and excitatory neurotransmitters in the human brain, respectively, which could regulate the spatial and temporal extent of neural activity throughout the brain (Akerman & Cline, 2007; Tessier & Broadie, 2009) . in vivo proton, magnetic resonance spectroscopy ( 1 H-MRS) provides a unique opportunity to noninvasively measure Glu levels in the human brain. Recent technical advances have been developed to quantify GABA levels using spectral editing techniques, such as the Mescher-Garwood Point Resolved Spectroscopy sequence (MEGA-PRESS) (Mescher, Merkle, Kirsch, Garwood, & Gruetter, 1998) . The MEGA-PRESS method allows GABA signals to be separated from other metabolites by taking advantage of known couplings within the GABA molecule (Harris, Saleh, & Edden, 2017; Mullins et al., 2014) . It has successfully been applied to measure GABA levels in patients with neuropsychiatric disorders (Bhattacharyya, Phillips, Stone, Bermel, & Lowe, 2013; Gao et al., 2015; Robertson, Ratai, & Kanwisher, 2016) and in healthy subjects (Balz et al., 2016; Gao et al., 2013) .
Recently, several clinical studies have investigated GABA levels in patients with MS using MEGA-PRESS, with diverse results. For instance, in sensorimotor regions, higher GABA levels have been reported in RRMS patients compared to healthy controls (HCs) (Nantes et al., 2017) but lower GABA levels have also been reported in secondary progressive MS patients (Cawley et al., 2015) . In addition, lower hippocampal GABA levels were also reported in secondary progressive MS (Cawley et al., 2015) . However, it remains to be determined whether GABA levels change in the hippocampus at the RRMS stage. Moreover, the glutamatergic and GABAergic signaling are tightly linked (Akerman & Cline, 2007) , and the resulting balance of excitation and inhibition in the brain regions influences individual differences in cognitive ability (de la Vega et al., 2014) . GABA enhancer (Sodium valproate) can relieve clinical symptoms in an animal model of MS, which is thought to be mediated by the inhibition of enhanced Glu excitotoxicity (Mandolesi, Gentile, Musella, & Centonze, 2015) . In contrast, another MS study observed reduced Glu levels, but not significant, in the hippocampal region, which correlated with worse memory function (Muhlert et al., 2014) . These inconsistent conclusions suggest that the changes in neurotransmitter levels in MS may be complex and specific for different brain circuits, which raises a fundamental question to be investigated. Spontaneous neuronal activities, identified by slow fluctuations in the blood oxygen level-dependent (BOLD) signals, are present in the brain at rest and well organized into specific functional networks, which represent spatial maps of correlations of these BOLD signal fluctuations within anatomically separate brain regions (Fox & Raichle, 2007) .
Resting-state functional magnetic resonance imaging (fMRI) studies have shown that the cognitive deficits in patients with MS are associated with aberrant hippocampal functional connectivity (FC) with temporal regions (Cruz-Gomez, Belenguer-Benavides, Martinez-Bronchal, Fittipaldi-Marquez, & Forn, 2016) , posterior cingulate cortex (PCC; Hulst et al., 2015) , and other regions (Tona et al., 2014) in patients with RRMS.
We hypothesized that patients with RRMS would present aberrant GABA and Glu levels, which might underlie the cognitive disability and disturbed functional integrations between the hippocampus and other brain regions. 1 H-MRS with MEGA-PRESS and PRESS were used to investigate GABA and Glu levels in the hippocampus in patients with RRMS and HCs. In addition, the intrinsic FC of the hippocampus was investigated using a resting-state seed-based FC analysis. The relationships between cognitive performance, MRS measurements, and FC strengths were analyzed to test our hypothesis.
| MATERIALS AND METHODS

| Subjects
Twenty-nine patients with RRMS, defined according to the revised
McDonald criteria (Polman et al., 2011) , from the Department of Neurology, Shandong Provincial Hospital were recruited for this study.
Exclusion criteria included a diagnosis of other neurological or psychiatric disorders and head trauma; relapse and steroid treatment within the preceding 3 months; hippocampal lesions that were visible on the MR images; intake of GABAergic agents (e.g., baclofen) before enrollment; severe depression (Beck Depression Inventory > 27) or use of antidepressant treatments; and a limitation of full activity with as Expanded Disability Status Scale (EDSS) score > 4. Twenty-nine ageand sex-matched HCs without neurological or psychiatric diseases were recruited from the local community. The demographic information was summarized in Table 1 .
All subjects were right-handed, as determined by the Edinburgh Handedness Inventory (Oldfield, 1971 
| Cognitive tests
The subjects' neuropsychological statuses were tested using the Audi- (Genova, DeLuca, Chiaravalloti, & Wylie, 2013; Hulst et al., 2015) . Each participant took approximately 60 min to complete all tests in a fixed order.
| MRI data acquisition
All subjects were scanned with a 3.0 T scanner (Philips "Achieva" TX, Best, The Netherlands) using an eight-channel phased-array head coil.
The T 1 -weighted three-dimensional (3D) turbo field echo sequence was used as a localizer and was acquired using the following parame- 
| Volumetric data processing
The absolute volumes of the left and right hippocampi were quantified from 3D T1-weighted images using FMRIB's Integrated Registration and Segmentation Tool (FSL FIRST) according to the standard procedure (Patenaude, Smith, Kennedy, & Jenkinson, 2011) . Normalized brain volume (NBV) was estimated with SIENAX (Smith et al., 2002) based on tissue-type segmentation with partial volume estimation.
WM lesions in the FLAIR images were segmented with a lesion prediction algorithm (Schmidt et al., 2012) as implemented in the Lesion Segmentation Tool (see Supplemental Methods for details).
| Spectral quantification
The MEGA-PRESS data were analyzed using "Gannet" (GABA-MRS Analysis Tool) in MATLAB 2010b (MathWorks, Natick, MA) with
Gaussian curve fitting of the GABA+ peaks (Edden, Puts, Harris, Barker, & Evans, 2014) . A 3 Hz exponential line broadening was applied. Because the signal detected at 3.02 ppm using these experimental parameters is also expected to contain contributions from both macromolecules (MM) and homocarnosine (Rothman, Behar, Prichard, & Petroff, 1997) , in the rest of this manuscript this signal is labeled GABA+ rather than GABA, to indicate the presence of these other compounds. The PRESS data were quantified using LCModel (version 6.3-0D) (Provencher, 1993) . The ratios of the integrals of neurotransmitter (GABA+ or Glu) and water signals, making corrections for T1 and T2 relaxation times and tissue composition, were used to calculate water-scaled GABA+ or Glu levels in institutional units (iu) (Gasparovic et al., 2006; Harris, Puts, & Edden, 2015; Mullins et al., 2014 ) (see Supplemental Methods for details).
Gannet provides normalized residual fitting errors for GABA+ levels, which can be interpreted quantitatively to assess measurement quality. Only spectra with a GABA+ fitting error of <15% were included in the final analysis. The reliability of the Glu measurement was assessed using the Cramer-Rao lower bounds (CRLB) as represented in LCModel and a commonly accepted CRLB criterion of 20% was chosen to reject low-quality spectra.
Each pixel in the 3D T1-weighted brain images was segmented as gray matter (GM), WM, or cerebrospinal fluid (CSF) using an automatic brain segmentation program, FAST (FMRIB's automated segmentation tool) in the FSL package (Oxford University, Oxford, UK) (Zhang, Brady, & Smith, 2001 ). VOIs were co-registered to the anatomical images using the "Re-creation of VOI" MATLAB tool (Montelius et al., 2009 ). Tissue GM fractions were obtained by calculating the ratio of GM volume to the GM + WM volumes in the VOIs.
| Hippocampal FC analysis
Preprocessing of the fMRI data was carried out using the toolbox for functional images and then segmented and registered to standard space using the nonlinear registration algorithm (Ashburner, 2007) . This process resulted in an FC coefficient map for each subject, which was converted into z-maps using Fisher's r-to-z transformation for the subsequent statistical analyses.
| Calculation of FC strengths between clusters
The FC strengths for each participant were then extracted using the clusters showing significant between-group differences in the hippocampal FC analysis. Briefly, the mean time course within each seed was extracted by averaging the time courses of all the voxels belonging to the seed. Subsequently, the mean time course was further used to compute correlation coefficients with the time courses of the left hippocampus. The resulting correlation coefficients were then converted to z-scores using Fisher's r-to-z transformation to improve the normality.
| Statistical analysis
All variables were assessed for normality using the KolmogorovSmirnov testing and histogram inspection. We used multivariate general linear model analyses to assess group differences and all analyses were corrected for age and gender. For the cognitive tests, education levels and NBV were also added as additional covariates. Genderspecific group differences were analyzed using the chi-square test.
Group differences in the FC z-maps were assessed using twosample t tests when age and gender were included as covariates (Colasanti et al., 2016) . Analyses were limited to include only regions that were recruited by at least one of the groups. These masks were computed by thresholding, binarizing, and then combining each within-group analysis (see Supplemental Methods). The analysis was corrected for multiple comparisons using the Gaussian Random Field theory (Z value for voxel >2.3, cluster-wise p < .05).
Partial correlation analyses between the hippocampal neurotransmitter levels and FC strengths were performed separately for patients with MS and HCs while controlling for age and gender. Age was considered as an important confounding factor, as we have previously observed an age-related decline in GABA+ levels (Gao et al., 2013) .
Gender-specific differences in hippocampal FC (Lopez-Larson, Anderson, Ferguson, & Yurgelun-Todd, 2011) have also been reported. The
Holm-Sidak approach (Aickin & Gensler, 1996) was applied to correct for multiple comparisons, and a two-tailed p value of <.05 was considered significant. Multiple stepwise regression analyses were then performed on the MS group, with cognitive scores or EDSS as the dependent variable and demographic and imaging (volumetric, spectroscopic, and FC) measurements as the predictive variables. All statistical analyses were conducted using PASW software (version 17.0, Chicago, IL).
3 | RESULTS
| Demographic and cognitive characteristics
The demographic and cognitive characteristics are listed in Table 1 .
The two groups did not exhibit significant differences in age, gender, or education level. All scores of the trials in the AVLT were Table S1 ). Therefore, the total score for the AVLT was presented here. Compared to the HCs, patients with MS performed worse on the AVLT, immediate recall of the ROCF and SDMT (p < .05).
| Volumetric differences
The patients showed reduced NBV compared with the HCs (p < .05, Table 2 ). There were no significant differences in the WM lesions volume, left or right hippocampal volume between the two groups.
| MRS
The fitting error of GABA+ and CRLB of Glu in all subjects was <15 Figure 2 ). In addition, the difference in Glu levels also reached significance (11.92 AE 1.55 iu vs. 11.02 AE 1.52 iu, p = .03, Figure 2 ). No significant difference in the Glu/GABA+ ratio (5.31 AE 1.27 vs. 5.57 AE 1.37, p = .50, Figure 2 ) was observed between groups. The coefficient of variance of GABA+ and Glu levels in the HC group was at 18 and 13%, respectively.
| Hippocampal FC
Compared with the HCs, MS patients exhibited lower connectivity with the left hippocampus in three clusters, including the bilateral medial prefrontal cortices (MPFC), left angular gyrus (AG), and bilateral PCC ( Figure 3 and Table 3 ). No areas showed higher hippocampal connectivity in the MS group. The seed-based FC analysis confirmed that the mean FC strengths between the hippocampus and the three clusters were all significantly decreased in patients with MS compared with those in the HCs (all p values <.01, Table 3 ). GABA+ levels also tended to be associated with the hippocampus-MPFC connectivity (ρ =0.43, p = .09). In addition, better performance on the AVLT was moderately associated with stronger connectivity between the hippocampus and AG (ρ = 0.58, p = .01). No other significant correlations were found between clinical performance and imaging parameters in the HC group. In the MS group, correlations were not observed between neurotransmitter levels and FC strengths (p > .05, uncorrected; Figure 4 ).
| Relationships between hippocampal GABA +/Glu levels and FC strengths
| Relationships between clinical performance and imaging measurements
In the MS group, the regression analyses found that the best predictors for AVLT scores (R 2 = 0.36, p = .003) were the GABA+ levels The data are presented as mean AE standard deviations. a Analyses that were corrected for inter-individual differences in age, gender and normalized brain volume (NBV). Abbreviations: HCs = healthy controls; HV = hippocampal volume.
FIGURE 2 Differences in the levels of neurotransmitter between the healthy control (HC) group and patients with multiple sclerosis (MS). CI = confidence interval; ratio = Glu/GABA+ Several pioneering MRS studies have revealed significantly lower GABA+ levels in the hippocampus of patients with secondary progressive MS (Cawley et al., 2015) , and lower Glu levels in the sensorimotor and parietal regions in patients with RRMS (Nantes et al., 2017) . This study is the first to show that patients with RRMS exhibit both lower GABA+ and Glu levels in the hippocampus, which may reflect dysfunctional glutamatergic and GABAergic systems. This finding is consistent with a number of previous animal studies: decreased levels of Glu, numbers of GABAergic interneurons and expression of glutamic acid decarboxylase (GAD), the enzyme responsible for synthesizing GABA, have been found in the cortex of mouse model of MS (Falco, Pennucci, Brambilla, & de Curtis, 2014; Massella et al., 2012; Orije et al., 2015) . The abnormalities in the excitatory and inhibitory neurotransmitter systems may be attributed to neurodegeneration and demyelination, which are prominent features observed in the hippocampus of patients with MS (Papadopoulos et al., 2009) . Moreover, the MS-induced demyelination would result in significant decreases in synaptic density and the levels of neuronal proteins required for glutamatergic and GABAergic neurotransmission (Dutta et al., 2011) .
Consistent with previous results (Schoonheim et al., 2012; Van Schependom et al., 2014) , cognitive dysfunction in patients with RRMS was most prominent in the domains of episodic memory and information processing speed. The reduced verbal memory and visuospatial memory observed in patients with MS correlated with decreased levels of GABA+ and of Glu in the hippocampus, respectively, but did not correlate with hippocampal FC strength. The association between memory and GABA+/Glu levels may not depend on macroscopic changes in the hippocampus, as both the hippocampal volume and GM fractions within the spectroscopic VOI did not correlate with memory or neurotransmitter measurements. In line with the current findings, a significant positive correlation was observed between Glu levels in the hippocampus and visuospatial memory in patients with RRMS, but not in healthy controls (Muhlert et al., 2014) . Abbreviations: AG = angular gyrus; BA = Brodmann area; FC = functional connectivity; MNI = Montreal Neurological Institute; MPFC = medial prefrontal cortex; PCC = posterior cingulate cortex.
One possible explanation for this finding is that learning and memory function in the hippocampus is largely dependent on the glutamate-dependent synaptic pathways from the entorhinal cortex to the dentate gyrus (Tamminga, Southcott, Sacco, Wagner, & Ghose, 2012) , whose volume has been shown to be related to visuospatial memory (Travis et al., 2014) . Brain microdialysis in a rat model of amnesia also revealed that hippocampal glutamate transmission closely correlated with the extent of the spatial memory impairment (Shimizu, Matsubara, Uezono, Kimura, & Shiono, 1998) . On the other hand, the impairments in language ability and word learning in patients with MS are associated with changes in the CA1 subfield Sicotte et al., 2008) , which contains GABAergic neurons (Pettit & Augustine, 2000) .
Resting-state FC between the hippocampus and its anatomic input or target areas, including the MPFC, PCC, and AG, was significantly decreased in patients with MS. In addition, better AVLT performance was positively associated with hippocampal FC to the AG in the HCs, but not patients. The hippocampus monosynaptically connects with the MPFC and PCC (Small, Schobel, Buxton, Witter, & Barnes, 2011) , and decreased resting-state FC between the hippocampus and these two target areas have been reported in patients with RRMS (Rocca et al., 2015; Roosendaal et al., 2010) . The AG is considered part of the ventral frontoparietal attention system (Chambers, Payne, Stokes, & Mattingley, 2004) , and the posterior part shows strong structural connectivity with the hippocampus via the inferior longitudinal fasciculus (Uddin et al., 2010) . The decrease in FC between the hippocampus and AG was consistent with one previous MS study (Rocca et al., 2015) . Moreover, one meta-analysis of 120 functional neuroimaging studies also identified the left AG as a core region for verbal memory tasks (Binder, Desai, Graves, & Conant, 2009) , which may explain the observed relationship between ALVT and hippocampal FC to the AG in the HCs.
Despite the widely accepted concept that FC is disturbed in patients with MS, the precise mechanisms are often poorly specified, mainly due to the limited techniques available to delineate the nature of brain FC in vivo. Our analysis in the HC group closely links the hippocampal FC strengths with the GABA+ levels and Glu/GABA+ ratios, providing a more precise delineation of the biochemical underpinnings of macro-scale brain connectivity. Intrinsic neural activity is generally regulated by the excitatory/inhibitory balance, which is closely related to the levels of Glu and GABA (Duncan, Wiebking, & Northoff, 2014) . In line with the current findings, a significant positive correlation was observed between the right amygdala-mPFC connectivity and GABA+ levels within the mPFC (Delli Pizzi et al., 2017) . In fact, the MPFC, PCC, and medial temporal lobes, including the hippocampus (Greicius, Supekar, Menon, & Dougherty, 2009) , and the AG (Passow et al., 2015; Uddin, Kelly, Biswal, Castellanos, & Milham, 2009) , are the major hubs of the default mode network (DMN), which is coherently active during the resting state and may promote mnemonic processing (Salami, Pudas, & Nyberg, 2014) . Both significant (Hu, Chen, Gu, & Yang, 2013; Kapogiannis, Reiter, Willette, & Mattson, 2013 ) and non-significant (Passow et al., 2015) correlations between excitatory (or inhibitory) neurotransmitters and entire connectivity of the DMN have been reported, depending on the choice of regions of interest.
In contrast, the hippocampal FC strengths were uncoupled with the GABA+ levels or Glu/GABA+ ratios in patients with MS. This finding indicated altered neurotransmitter control of synchronized BOLD signal fluctuations between the hippocampus and its input or target areas. Future work will aim to examine whether patients with MS also show changes in GABA and/or glutamate levels in other regions connected to the hippocampus and whether these changes help to explain the cognitive impairment and decrease in connectivity strengths. In fact, WM lesions also impair FC between the hippocampus and other brain regions. This hypothesis was validated by Rocca et al. (2015) , who reported a strong correlation between a high brain T2 lesion volume and reduced hippocampal resting-state FC. However, similar results were not observed in the current study and other FC studies in patients with MS (Colasanti et al., 2016; Hulst et al., 2015; Rocca et al., 2014) . These inconsistencies might be attributed to the diverse locations of the lesions in the frontal, temporal, parietal, and cingulate regions, and therefore whole-brain lesion volume might not be a stable and precise index to explain the abnormalities of hippocampal circuits in patients with MS.
The determination of cognitive ability by excitatory and inhibitory neurotransmitters levels rather than FC in patients with MS strengthens the use of MRS as a useful tool for the objective assessment of MSinduced cognitive impairments. Furthermore, the fact that cognitive impairments are related to the levels of excitatory and inhibitory neurotransmitters in the hippocampus of patients in the remitting stage rather than in the progressive stage (Cawley et al., 2015) helps to address a problem regarding the window of opportunity for clinical intervention. A previous animal study also supports the potential of using positive GABA receptor modulators to manage MS (Gilani, Dash, Jivrajani, Thakur, & Nivsarkar, 2014) . Therefore, pharmacological therapies targeting these neurotransmitter systems might be valuable in the future.
There is currently no consensus in terms of the relative involvement of the left and right hippocampi in MS. The majority of structural MRI studies found that they were affected equally (Hulst et al., 2015; Sicotte et al., 2008) . Previous functional MRI study also revealed similar patterns of FC abnormalities for the left and right hippocampi (Rocca et al., 2015) . Moreover, the reduced GABA concentration in the right hippocampus had been reported in patients with progressive MS (Cawley et al., 2015) . Therefore, although the current study only investigated the MRS and FC changes for the left hippocampus, the symmetric findings are to be expected for the contralateral one.
The primary limitation of this study is that the relatively low amplitude of the GABA signal required the use of a relatively large VOI, a volume that contains, but is by no means restricted to, left hippocampus. The VOI also included some WM from surrounding tissue and small parts of neighboring medial temporal lobe structures. However, patients and controls showed no differences in the GM fractions. Moreover, to account for differences in metabolite levels between GM and WM, GABA+, and Glu levels were corrected to a voxel of pure GM using the method proposed by Harris et al. (Harris et al., 2015) . In addition, it has been estimated that GABA is approximately seven times greater in GM than in WM, which suggests that the majority of the GABA level quantified with MRS derives from the GM (Ganji et al., 2014) . Second, the edited GABA signal that was detected in this study contains a significant contribution from coedited macromolecules. New methods for macromolecule suppression are being developed (Edden et al., 2016) . However, it is currently thought that the GABA+ measurement is the most robust one available, despite its contaminations (Mullins et al., 2014) . Third, the temporal resolution of fMRI precludes determining whether FC between two regions reflects a direct (potentially monosynaptic) connection or is conducted across multiple synapses via intermediate nodes (Greicius et al., 2009 ). Fourth, although we excluded patients with macroscopic lesions in the hippocampi, the imaging measurements may be contaminated by smaller foci that only could be detected by MRI with special sequences (Roosendaal et al., 2008) or higher fields (Kilsdonk et al., 2016) . Fifth, the majority of GABA is located in two pools within neurons-the cytoplasm and the presynaptic vesicles (Kwon et al., 2014) . However, MRS is only capable of detecting total GABA within the prescribed localized region, and it cannot distinguish between these separate functional pools of GABA (Stagg, Bachtiar, & Johansen-Berg, 2011) . Therefore, the scope of our study to introduce GABAergic neurotransmission as a treatment target for MS may be limited.
| CONCLUSION
By combining J-difference-edited MRS and resting-state fMRI, we provided evidence that hippocampal GABA+ and Glu levels, as well as EB016089, P41 EB015909).
